We are live on ! Find out more
DARE icon

Dare Bioscience

16 hedge funds and large institutions have $624K invested in Dare Bioscience in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

14% more funds holding

Funds holding: 1416 (+2)

0.02% less ownership

Funds ownership: 0.43%0.4% (-0.02%)

14% less capital invested

Capital invested by funds: $726K → $624K (-$102K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

DARE Hedge Fund Activity: Q3 2019 in Review

16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2019, worth a combined $624K — down 14% from $726K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DARE positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $3.44K. The largest seller was Susquehanna International Group, cutting an estimated $25.4K.

  • 16 institutional investors held Dare Bioscience (DARE) as of Q3 2019, up from 14 in Q2 2019.
  • Funds reported $624K of Dare Bioscience stock for Q3 2019, down 14% quarter-over-quarter.
  • 4 funds opened new Dare Bioscience positions in Q3 2019 and 2 closed out, a net change of +2 holders.
  • The largest Dare Bioscience buyer in Q3 2019 was Deutsche Bank, an estimated $3.44K added.
  • The largest Dare Bioscience seller in Q3 2019 was Susquehanna International Group, an estimated $25.4K sold.

Based on aggregated 13F filings for Q3 2019.